(R)-Azasetron besylate (SENS-401), an orally active calcineurin inhibitor, has been demonstrated to mitigate cisplatin-induced hearing loss and cochlear damage [1][2].
Molecular Weight:
507.99
CAS Number:
[2025360-91-0]
Formula:
C23H26ClN3O6S
Target:
Phosphatase
T78217
* VAT and and shipping costs not included. Errors and price changes excepted